Showing 1 - 8 of 8
Objective: We estimate the effects of Reference Pricing, a drug cost control policy introduced by the BC Ministry of Health Pharmacare program in 1995, on its program expenditures for seniors, out of pocket costs paid by its senior beneficiaries, indicators of beneficiary health status and...
Persistent link: https://www.econbiz.de/10005763258
(see SEDAP 70 for abstract)
Persistent link: https://www.econbiz.de/10005763264
The 1984 Canada Health Act does not require that the provinces subsidize prescription drugs. Many provinces do, however, provide categorical coverage to the elderly, social assistance recipients and others, although the generosity of coverage is highly variable. A system of parallel private...
Persistent link: https://www.econbiz.de/10005763326
(see QSEP 369 for abstract)
Persistent link: https://www.econbiz.de/10005181106
Objective: We estimate the effects of Reference Pricing, a drug cost control policy introduced by the BC Ministry of Health Pharmacare program in 1995, on its program expenditures for seniors, out of pocket costs paid by its senior beneficiaries, indicators of beneficiary health status and...
Persistent link: https://www.econbiz.de/10005181109
(see QSEP 369 for abstract)
Persistent link: https://www.econbiz.de/10005181110
The 1984 Canada Health Act does not require that the provinces subsidize prescription drugs. Many provinces do, however, provide categorical coverage to the elderly, social assistance recipients and others, although the generosity of coverage is highly variable. A system of parallel private...
Persistent link: https://www.econbiz.de/10005181125
(see SEDAP 70 for abstract)
Persistent link: https://www.econbiz.de/10005404416